[Skip to Content]
[Skip to Content Landing]
Views 577
Citations 0
Comment & Response
September 1, 2015

Assessing Eligibility for Anticoagulation After Diagnosis of Atrial Fibrillation—Reply

Author Affiliations
  • 1University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, England
JAMA. 2015;314(9):949-950. doi:10.1001/jama.2015.8995

In Reply Many of the clinical risk scores currently used in everyday practice have not been formally tested in prospective randomized clinical trials. Variability in INRs and TTR is dependent on many clinical risk factors,1 and the SAMe-TT2R2 score simply puts the more common clinical factors into a simple acronym for easy use in everyday clinical practice2 rather than relying on guesswork.

First Page Preview View Large
First page PDF preview
First page PDF preview